ScholarIQanswers from OpenAlex

What Arguments against COVID-19 Vaccines Run on Facebook in Poland: Content Analysis of Comments

PaperCitations, authors & open-access status

What Arguments against COVID-19 Vaccines Run on Facebook in Poland: Content Analysis of Comments is a paper indexed in ScholarIQ from OpenAlex.

How many citations does What Arguments against COVID-19 Vaccines Run on Facebook in Poland: Content Analysis of Comments have?

ScholarIQcitation count

What Arguments against COVID-19 Vaccines Run on Facebook in Poland: Content Analysis of Comments has 67 citations in the OpenAlex counts ScholarIQ stores.

When was What Arguments against COVID-19 Vaccines Run on Facebook in Poland: Content Analysis of Comments published?

ScholarIQyear

What Arguments against COVID-19 Vaccines Run on Facebook in Poland: Content Analysis of Comments has 2021 year in the ScholarIQ index.

What is the open-access status of What Arguments against COVID-19 Vaccines Run on Facebook in Poland: Content Analysis of Comments?

ScholarIQoa status

What Arguments against COVID-19 Vaccines Run on Facebook in Poland: Content Analysis of Comments has gold oa status in the ScholarIQ index.

What is the DOI of What Arguments against COVID-19 Vaccines Run on Facebook in Poland: Content Analysis of Comments?

ScholarIQdoi

The DOI for What Arguments against COVID-19 Vaccines Run on Facebook in Poland: Content Analysis of Comments is on the source record.

What is the PMID of What Arguments against COVID-19 Vaccines Run on Facebook in Poland: Content Analysis of Comments?

ScholarIQpmid

The PMID for What Arguments against COVID-19 Vaccines Run on Facebook in Poland: Content Analysis of Comments is on the source record.

What is the OpenAlex record for What Arguments against COVID-19 Vaccines Run on Facebook in Poland: Content Analysis of Comments?

ScholarIQopenalex

The OpenAlex for What Arguments against COVID-19 Vaccines Run on Facebook in Poland: Content Analysis of Comments is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial